Ministry of Health suspends Diane 35

WAM Dubai, Feb 5th, 2013 (WAM) — The Ministry of Health has called the local health authorities and directors of medical districts, public and private hospitals and private clinics to temporarily suspend the usage of Diane 35 due to its side effects.

Based on the recommendations of the French Drugs Agency “ANSM” regarding the aforementioned medicine and similar products that are used for the treatment of acne and other dermatology diseases which have a hormonal origin. Studies showed that their usage may cause blood clots, the ministry said today.

Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Medical Practices and Licensing and Chairman of the higher committee for registration and pricing remarked: “The ministry recommended the temporary suspension of the above mentioned drug and all similar products in addition to the importation and marketing of the drug until the final evaluation of the product is done by international health authorities”.

He also stated that patients using the drug should not stop using the medicines by themselves but consult their doctor. He noted that doctors must not prescribe new prescriptions or renew the prescription of the medicine.

“The product is registered in the Ministry of Health according to the rules and regulations of the drugs registration operations and process. However, this does not prevent the ministry from using the correct safe and healthy procedures in case any side effects appear due to the usage of any medicine”, Al Amiri elaborated.

The official explained that the French Drug Agency discovered blood clots complications which are already mentioned in the drug’s internal newsletter. With the increasing number of these cases, the French agency decided to suspend this product.

The European Drugs Authority is currently examining and studying the product in its laboratories and coordinating with the UAE Ministry of Health regarding to the continuation of the product or withdrawing it completely from the markets.

Al Amiri explained that incase of any side effects or accidents, the community members are requested to fill in the form available on the website:

In case of emergencies or side effects of the product, one can reach to registration and pharmaceutical control administration on the following direct telephone numbers: 026117391 or 026117318, fax number: 02-6313742 or email address: WAM/AM